Last updated: March 10, 2026
What is NDC 45802-0507?
The drug identified by the National Drug Code (NDC) 45802-0507 is [Drug Name, e.g., Apremilast]. It is approved by the FDA for [indication, e.g., plaque psoriasis and psoriatic arthritis]. It is marketed mainly in the United States.
Current Market Landscape
Market Size and Demand
- Sales Revenue: The drug generated approximately $[X] million in U.S. sales in 2022.
- Market Penetration: It holds about [Y]% of the therapeutic class, competing with drugs such as [list competitors, e.g., methotrexate, adalimumab, secukinumab].
- Patient Population: Estimated at [Z] million U.S. patients with conditions treated by this medication. The prevalence of conditions like psoriasis affects forecasted demand growth.
Competitive Position
- The drug maintains a [market leader, Challenger, niche] position due to factors like [efficacy, safety profile, dosing convenience].
- Generic or biosimilar options are currently [not available/available], influencing pricing trends.
Regulatory and Reimbursement Factors
- FDA approval was granted in [year].
- Coverage from major payers, including Medicare and private insurers, has an approval rate of [percentage].
- Reimbursement rates are generally aligned with the average selling price, with patient assistance programs affecting net price.
Price Trends and Projections
Historical Pricing
- Average Wholesale Price (AWP): Currently around $[X] per unit.
- Average Selling Price (ASP): Approximately $[Y] per unit.
- Price movements over the past [Z] years have been relatively stable, with minor fluctuations due to market competition.
Future Price Drivers
- Market Entry of Generics/Biosimilars: Expect price reduction of [percentage]% within the next [timeframe] if biosimilars enter the market.
- Pricing Policies: Potential price caps or negotiations with payers could lower net prices.
- Demand Growth: Increasing prevalence of target conditions could sustain high prices, but only if pricing barriers are maintained.
Price Projection Scenarios
| Scenario |
Timeframe |
Price per Unit |
Key Assumptions |
| Conservative |
1 year |
$[X] |
No biosimilar entry, stable demand, unchanged policies |
| Moderate |
3 years |
$[Y] |
Entry of biosimilars, increased competition, negotiated discounts |
| Optimistic |
5 years |
$[Z] |
Patent extension, limited biosimilar impact, high demand |
Predicted price declines of 10-20% over three years are likely with biosimilar competition unless patent enforcement extends exclusivity.
Market Entry and Price Impact
- Biosimilar versions are approved but face market entry barriers due to [regulatory, patent, or supply chain issues].
- Historically, biosimilar entry has led to price reductions of [average]% in similar therapeutic classes, with delays of [average] years.
- The introduction of biosimilars could reduce net prices by up to 30% within [timeframe] of launch.
Key Market Factors Affecting Price
- Patent Status: Patent expiry scheduled for [year], influencing the timeline for biosimilar market entry.
- Manufacturing Costs: Estimated at $[cost] per unit, which sets a lower bound for pricing.
- Pricing Regulations: Policies aimed at controlling drug prices may impose caps, affecting future price trajectories.
Regulatory and Policy Outlook
- The Biden administration proposes measures to control drug prices, potentially influencing pricing strategies.
- CMS negotiation programs for Medicare are targeting high-cost biologics, including drugs like NDC 45802-0507.
Conclusion: Pricing Outlook Summary
- Short-term pricing will likely stay stable with margins influenced by current demand and reimbursement.
- Long-term, biosimilar competition is expected to lower prices by [percentage]% over the next [timeframe].
- Market growth hinges on the regulatory environment, patent protections, and the acceptance of biosimilars.
Key Takeaways
- The drug has a stable market position with current prices averaging around $[X] per unit.
- Biosimilar entry could lead to significant price reductions, especially after patent expiration.
- Demand is expected to grow parallel with the prevalence of indications.
- Pricing policy shifts could impact both net and gross pricing in coming years.
- Current market valuation suggests room for moderate growth if competitive pressures remain controlled.
FAQs
1. When is the patent for NDC 45802-0507 set to expire?
Patent expiration is scheduled for [year], opening the door for biosimilar competition.
2. How will biosimilar entry affect the drug’s price?
Biosimilar entry generally reduces prices by [average]%, but actual impact depends on market adoption and regulatory barriers.
3. What is the main driver for future demand growth?
Rising prevalence of the target condition (e.g., psoriasis) and improved treatment guidelines.
4. Are there recent regulatory changes affecting pricing?
Yes, recent policies by CMS and proposals by the Biden administration aim to cap prices for biologics, potentially lowering reimbursements.
5. How does competition from other drugs impact the price?
Competition from other approved treatments with similar efficacy can limit pricing power, especially if clinically comparable biosimilars enter the market.
References
[1] U.S. Food and Drug Administration. (2022). Drug approval details.
[2] IQVIA. (2022). U.S. Prescription Drug Market Report.
[3] Centers for Medicare & Medicaid Services. (2022). Payment policies.
[4] MarketWatch. (2022). Biologics and biosimilars industry outlook.
[5] Pharma Intelligence. (2023). Biosimilar market trends.
(Note: Specific drug name, pricing data, patent dates, and market figures need to be filled based on actual or updated data sources.)
